LENSERTER Trademark

Trademark Overview


On Wednesday, July 7, 1971, a trademark application was filed for LENSERTER with the United States Patent and Trademark Office. The USPTO has given the LENSERTER trademark a serial number of 72396736. The federal status of this trademark filing is EXPIRED as of Saturday, August 23, 2003. This trademark is owned by OPTIKON LABORATORIES. The LENSERTER trademark is filed in the Medical Instrument Products category with the following description:

APPARATUS FOR INSERTING CONTACT LENSES INTO THE HUMAN EYE

General Information


Serial Number72396736
Word MarkLENSERTER
Filing DateWednesday, July 7, 1971
Status900 - EXPIRED
Status DateSaturday, August 23, 2003
Registration Number0947654
Registration DateTuesday, November 21, 1972
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesAPPARATUS FOR INSERTING CONTACT LENSES INTO THE HUMAN EYE

Classification Information


International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes044
Class Status Code9 - Expired
Class Status DateSaturday, August 23, 2003
Primary Code044
First Use Anywhere DateWednesday, May 19, 1971
First Use In Commerce DateWednesday, May 19, 1971

Trademark Owner History


Party NameQUANTERRON, INC.
Party Type42 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressBURNSVILLE, MN 55337

Party NameOPTIKON LABORATORIES
Party Type30 - Original Registrant
Legal Entity Type02 - Partnership
AddressWEST CORNWALL, CT 06796

Trademark Events


Event DateEvent Description
Friday, August 29, 2003TEAS CHANGE OF CORRESPONDENCE RECEIVED
Saturday, August 23, 2003CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Wednesday, April 14, 1993REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Monday, February 22, 1993REGISTERED - SEC. 9 FILED/CHECK RECORD FOR SEC. 8
Tuesday, April 11, 1978REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.